Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,771 | 8,910 | 8,238 | 9,572 | 12,063 |
| Marketable Securities | 8,740 | 12,959 | 5,200 | 10,200 | 12,200 |
| TOTAL | $18,751 | $24,298 | $15,534 | $21,836 | $26,558 |
| Non-Current Assets | |||||
| PPE Net | 73 | 81 | 89 | 11 | 12 |
| Intangibles | 119 | 123 | 126 | 130 | 134 |
| TOTAL | $192 | $204 | $215 | $141 | $146 |
| Total Assets | $18,943 | $24,502 | $15,749 | $21,977 | $26,704 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 514 | 1,220 | 1,223 | 1,387 | 903 |
| Accrued Expenses | 4,243 | 3,391 | 2,141 | 2,143 | 2,116 |
| TOTAL | $4,757 | $4,611 | $3,364 | $3,530 | $3,019 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,757 | $4,611 | $3,364 | $3,530 | $3,019 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 115 | 115 | 114 | 101 | 101 |
| Common Shares | 16 | 16 | 142 | 142 | 142 |
| Retained earnings | -537,451 | -531,198 | -524,334 | -517,420 | -511,368 |
| TOTAL | $14,186 | $19,891 | $12,385 | $18,447 | $23,685 |
| Total Liabilities And Equity | $18,943 | $24,502 | $15,749 | $21,977 | $26,704 |